Europe - Euronext Milan - BIT:ARBS - IT0005386369 - Common Stock
The current stock price of ARBS.MI is 3.08 EUR. In the past month the price increased by 22.22%.
ChartMill assigns a technical rating of 5 / 10 to ARBS.MI.
ChartMill assigns a fundamental rating of 4 / 10 to ARBS.MI. While ARBS.MI seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ARBS.MI reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 37.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 42.38% | ||
| ROA | 13.59% | ||
| ROE | 16.33% | ||
| Debt/Equity | 0.02 |
7 analysts have analysed ARBS.MI and the average price target is 3.88 EUR. This implies a price increase of 25.84% is expected in the next year compared to the current price of 3.08.
Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.
ARTERRA BIOSCIENCE SPA
via Benedetto Brin, 69
Naples NAPOLI IT
Employees: 30
Phone: 390816584411
Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.
The current stock price of ARBS.MI is 3.08 EUR. The price decreased by -1.28% in the last trading session.
ARTERRA BIOSCIENCE SPA (ARBS.MI) has a dividend yield of 4.19%. The yearly dividend amount is currently 0.11.
ARBS.MI has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
ARBS.MI stock is listed on the Euronext Milan exchange.
You can find the ownership structure of ARTERRA BIOSCIENCE SPA (ARBS.MI) on the Ownership tab.